This expansion includes the provision of intimate hygiene products such as reusable pads, tampons, menstrual cups, and more
Pee Safe has partially closed its series B round. The company has received $3 million out of its total round size of $6 million (approximately Rs 50 crore). The funding was led by Natco Pharma and Rainmatter Health, supported by Nithin Kamath and Nikhil Kamath, founders of Zerodha. Alkemi Growth Capital, an existing investor, also participated in the round.
This expansion includes the provision of intimate hygiene products such as reusable pads, tampons, menstrual cups, and more.
Vikas Bagaria, the Founder and CEO of Pee Safe said, “We are thrilled to secure strategic funding from esteemed pharmaceutical and wellness players like Natco Pharma and Rainmatter. This funding will accelerate our expansion efforts and establish us as the leading brand in the rapidly growing intimate wellness sector, which boasts a remarkable CAGR of 16 per cent. Over the past five years, Pee Safe has achieved a remarkable growth rate of 100 per cent CAGR, surpassing market expectations.”
Pee Safe was established with the primary goal of addressing a significant concern for women: the risk of Urinary Tract Infections resulting from unsanitary toilet seats and the lack of access to hygienic public restrooms.